- Home
- HUSA vs MTVA Comparison
HUSA vs MTVA Comparison
Compare HUSA & MTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUSA
- MTVA
- Stock Information
- Founded
- HUSA N/A
- MTVA 2014
- Country
- HUSA United States
- MTVA United States
- Employees
- HUSA N/A
- MTVA N/A
- Industry
- HUSA Oil & Gas Production
- MTVA
- Sector
- HUSA Energy
- MTVA
- Exchange
- HUSA Nasdaq
- MTVA NYSE
- Market Cap
- HUSA 16.9M
- MTVA 16.8M
- IPO Year
- HUSA N/A
- MTVA N/A
- Fundamental
- Price
- HUSA $1.42
- MTVA $1.74
- Analyst Decision
- HUSA
- MTVA Strong Buy
- Analyst Count
- HUSA 0
- MTVA 1
- Target Price
- HUSA N/A
- MTVA $12.00
- AVG Volume (30 Days)
- HUSA 3.0M
- MTVA 57.9K
- Earning Date
- HUSA 11-14-2024
- MTVA 03-27-2025
- Dividend Yield
- HUSA N/A
- MTVA N/A
- EPS Growth
- HUSA N/A
- MTVA N/A
- EPS
- HUSA N/A
- MTVA N/A
- Revenue
- HUSA $640,348.00
- MTVA N/A
- Revenue This Year
- HUSA N/A
- MTVA N/A
- Revenue Next Year
- HUSA N/A
- MTVA N/A
- P/E Ratio
- HUSA N/A
- MTVA N/A
- Revenue Growth
- HUSA N/A
- MTVA N/A
- 52 Week Low
- HUSA $0.96
- MTVA $1.51
- 52 Week High
- HUSA $3.20
- MTVA $6.75
- Technical
- Relative Strength Index (RSI)
- HUSA 45.28
- MTVA N/A
- Support Level
- HUSA $1.43
- MTVA N/A
- Resistance Level
- HUSA $1.75
- MTVA N/A
- Average True Range (ATR)
- HUSA 0.25
- MTVA 0.00
- MACD
- HUSA -0.05
- MTVA 0.00
- Stochastic Oscillator
- HUSA 4.55
- MTVA 0.00
About HUSA Houston American Energy Corporation
Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.